Clinical Cancer Research: 1 (10)

Antibody to ras proteins in patients with colon cancer.

M Takahashi, W Chen, D R Byrd, M L Disis, E S Huseby, H Qin, L McCahill, H Nelson, H Shimada and K Okuno

Clin Cancer Res October 1 1995 1 (10) 1071-1077;
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer.

J Grøndahl-Hansen, H A Peters, W L van Putten, M P Look, H Pappot, E Rønne, K Dano, J G Klijn, N Brünner and J A Foekens

Clin Cancer Res October 1 1995 1 (10) 1079-1087;
Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion.

M M Webber, A Waghray and D Bello

Clin Cancer Res October 1 1995 1 (10) 1089-1094;
Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas.

Y Kitadai, L M Ellis, Y Takahashi, C D Bucana, H Anzai, E Tahara and I J Fidler

Clin Cancer Res October 1 1995 1 (10) 1095-1102;
Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.

F A Sinicrope, J Hart, F Michelassi and J J Lee

Clin Cancer Res October 1 1995 1 (10) 1103-1110;
Association of p53 mutations with metastatic prostate cancer.

J A Eastham, A M Stapleton, A E Gousse, T L Timme, G Yang, K M Slawin, T M Wheeler, P T Scardino and T C Thompson

Clin Cancer Res October 1 1995 1 (10) 1111-1118;
Expression of transforming growth factor beta and transforming growth factor beta receptors on AIDS-associated Kaposi's sarcoma.

I F Ciernik, B H Krayenbühl Ciernik, C J Cockerell, J D Minna, A F Gazdar and D P Carbone

Clin Cancer Res October 1 1995 1 (10) 1119-1124;
Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.

S M Woerner, M Givehchian, M Dürst, A Schneider, S Costa, P Melsheimer, J Lacroix, M Zöller and M K Doeberitz

Clin Cancer Res October 1 1995 1 (10) 1125-1132;
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

E Gupta, O I Olopade, M J Ratain, R Mick, T M Baker, F K Berezin, A B Benson 3rd and M E Dolan

Clin Cancer Res October 1 1995 1 (10) 1133-1138;
Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.

J Rinehart, K A Margolin, P Triozzi, E Hersh, M Campion, D Resta and D Levitt

Clin Cancer Res October 1 1995 1 (10) 1139-1144;
Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously.

R P Whitehead, K D Friedman, D A Clark, K Pagani and L Rapp

Clin Cancer Res October 1 1995 1 (10) 1145-1152;
Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli.

L Sreerama, M W Hedge and N E Sladek

Clin Cancer Res October 1 1995 1 (10) 1153-1163;
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.

D M Vail, E G MacEwen, I D Kurzman, R R Dubielzig, S C Helfand, W C Kisseberth, C A London, J E Obradovich, B R Madewell and C O Rodriguez Jr

Clin Cancer Res October 1 1995 1 (10) 1165-1170;
Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm.

M X Wei, T Tamiya, R J Rhee, X O Breakefield and E A Chiocca

Clin Cancer Res October 1 1995 1 (10) 1171-1177;
Elimination of human leukemia by monoclonal antibodies in an athymic nude mouse leukemia model.

Y Xu and D A Scheinberg

Clin Cancer Res October 1 1995 1 (10) 1179-1187;
Prognostic value of amplification of c-erb-B2 in bladder carcinoma.

U Lönn, S Lönn, S Friberg, B Nilsson, C Silfverswärd and B Stenkvist

Clin Cancer Res October 1 1995 1 (10) 1189-1194;
Tumor-associated antigens as prognostic factors for recurrence in 382 patients with primary transitional cell carcinoma of the bladder.

P Allard, Y Fradet, B Têtu and P Bernard

Clin Cancer Res October 1 1995 1 (10) 1195-1202;
p53 mutation and tamoxifen resistance in breast cancer.

R M Elledge, S Lock-Lim, D C Allred, S G Hilsenbeck and L Cordner

Clin Cancer Res October 1 1995 1 (10) 1203-1208;
Identification of a novel gene, selectively up-regulated in human carcinomas, using the differential display technique.

O Kocher, P Cheresh, L F Brown and S W Lee

Clin Cancer Res October 1 1995 1 (10) 1209-1215;
Differential expression of Mr 70,000 heat shock protein in normal, premalignant, and malignant human uterine cervix.

R Ralhan and J Kaur

Clin Cancer Res October 1 1995 1 (10) 1217-1222;
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.

Y Xu, D C Gaudette, J D Boynton, A Frankel, X J Fang, A Sharma, J Hurteau, G Casey, A Goodbody and A Mellors

Clin Cancer Res October 1 1995 1 (10) 1223-1232;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Clinical Cancer Research